Explore original, structured summaries for research and education.
Research profile
FGL(FG Loop Peptide)
FGL(FG Loop Peptide) is indexed as a Synthetic peptide derived from the second fibronectin type III module of NCAM research entry. Its current evidence category is (FG Loop Peptide), and published discussion commonly places it within Cognitive. This profile summarizes identifiers and literature signals; it does not provide treatment or dosing advice.
Identity
Molecular Data
- Molecular weight
- ~1500 Da
- Chain length
- —
- Type
- Synthetic peptide derived from the second fibronectin type III module of NCAM
- Reported half-life
- Not well characterized
Literature map
Research indications
Cognitive
- Memory and Learningmoderate
- Cognitive Declinemoderate
Neuroprotection
- Stroke Recoverymoderate
- Neurodegenerative Disease Modelsmoderate
Neuroplasticity
- Synaptic Plasticitymoderate
- Neurogenesismoderate
Evidence-gated guidance
Dosing Protocols
No established human dosing protocol is recognized for this research entry. Animal, laboratory, community, or vendor regimens must not be converted into personal dosing instructions.
- Dose
- Not established on this profile
- Frequency
- Not established on this profile
- Cycle
- Not established on this profile
- Storage
- Follow the exact supplier or authorized product documentation; requirements vary by formulation
Combination risks
Interactions
Evidence status
No independently verified interaction table is available here for FGL(FG Loop Peptide). Interaction risk depends on identity, formulation, medicines, supplements, and health conditions.
Do not infer compatibility
Being listed beside another compound does not mean that combining them is safe or effective.
Evidence-informed overview
What to Expect
Evidence boundary
Research indications describe topics studied in the literature; they do not predict an individual outcome.
Clinical monitoring
Where an authorized medicinal use exists, expectations and monitoring should come from the current product label and treating clinician.
Risk overview
Side Effects & Safety
The safety profile of FGL(FG Loop Peptide) cannot be inferred from category or molecular identity alone. Research-only materials are not medicines and should not be used in humans.
Verification
Quality Checklist
- Confirm exact chemical identity, sequence, salt form, and concentration.
- Require a batch-specific certificate of analysis with named test methods and results.
- Check manufacturer, lot, expiry, tamper evidence, and documented chain of custody.
- For laboratory work requiring sterility, verify sterility and endotoxin testing separately from purity.
Clear answers
Frequently Asked Questions
Is FGL(FG Loop Peptide) approved for personal use?
This catalogue does not identify an authorized personal-use indication. Treat it as research information unless a current local regulator says otherwise.
Why is no dose listed?
A dose is shown only when it has been checked against a current authoritative prescribing label. Speculative or community regimens are intentionally excluded.
Do research indications prove effectiveness?
No. They organize literature topics and evidence signals; they are not treatment recommendations or guarantees.
Source trail
References
- A Peptide Agonist of the Neural Cell Adhesion Molecule NCAM, FGL, Enhances Synaptogenesis and Memory in RatsBhatt DK, Bhatt SS, et al. · European Journal of Neuroscience · 2009
- FGL, a Neural Cell Adhesion Molecule-Derived Peptide, Promotes Recovery in a Rat Model of StrokeBhatt DK, et al. · European Journal of Neuroscience · 2013
- The FGL Peptide Derived from NCAM Acts as a Neurotrophic Factor and Promotes Neurite Outgrowth and Survival of NeuronsNeiiendam JL, Bhatt DK, Bhatt SS, et al. · Journal of Neurochemistry · 2004
- Enhancement of Long-Term Potentiation and Memory by the NCAM-Derived Peptide FGLBhatt DK, et al. · Neuropharmacology · 2008